New non-steroidal anti-inflammatory can inhibit the cytokine storm and preserve innate immunity
Very early in the COVID-19 pandemic clinical trials in patients hospitalized with COVID-19 confirmed that corticosteroids like dexamethasone reduced mortality, but they were harmful when applied at the first COVID-19 symptoms, due to the weakening of innate antiviral immunity, leading to delayed viral clearance and adverse outcomes in severe viral pneumonias.
United States Sri Lanka Jose Mar Generalitat Valenciana Excellence Program Spanish Agency Of Medicaments
Source: news-medical.net